EDGEWISE THERAPEUTICS INC (EWTX)
Sector: Health Care
Sector: Health Care
Compensation data for top executives (showing up to 3 years of data)
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Kevin Koch, Ph.D. President and Chief Executive Officer | 2025 | $670,000 | $0 | $1,171,625 | $5,041,621 | $462,300 | $14,000 | $7,359,546 |
| 2024 | $618,675 | $0 | $1,225,469 | $5,300,903 | $442,353 | $13,800 | $7,601,200 | |
| 2023 | $594,880 | $0 | $0 | $3,070,335 | $297,440 | $13,200 | $3,975,855 |
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Robert Blaustein, M.D., Ph.D. Former Chief Development Officer | 2025 | $525,000 | $0 | $999,475 | $2,801,305 | $227,605 | $14,000 | $4,567,385 |
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Michael P. Nofi Chief Financial Officer | 2025 | $67,813 | $0 | $799,750 | $3,387,209 | $29,887 | $0 | $4,284,659 |
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Behrad Derakhshan, Ph.D. Chief Operating Officer | 2025 | $520,000 | $0 | $401,700 | $1,728,428 | $269,100 | $14,000 | $2,933,228 |
| 2024 | $478,400 | $0 | $394,281 | $1,705,376 | $310,960 | $7,176 | $2,896,193 | |
| 2023 | $446,667 | $0 | $0 | $1,125,650 | $184,000 | $0 | $1,756,317 |
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Joanne M. Donovan, M.D., Ph.D. Chief Medical Officer | 2025 | $530,358 | $0 | $376,594 | $1,620,389 | $243,965 | $14,000 | $2,785,306 |
| 2024 | $507,520 | $0 | $394,281 | $1,705,376 | $303,497 | $13,800 | $2,924,474 | |
| 2023 | $488,000 | $0 | $0 | $1,020,444 | $195,200 | $13,200 | $1,716,844 |
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Alan Russell, Ph.D. Co-Founder and Chief Scientific Officer | 2025 | $499,580 | $0 | $376,594 | $1,620,389 | $229,807 | $8,479 | $2,734,849 |
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| R. Michael Carruthers Former Chief Financial Officer | 2025 | $465,694 | $0 | $392,707 | $1,500,845 | $214,219 | $14,000 | $2,587,465 |